Cargando…
An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies
Autores principales: | Staehli Hodel, Eva Maria, Kay, Katherine, Hayes, Daniel, Terlouw, Anja, Hastings, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472405/ http://dx.doi.org/10.1186/1475-2875-11-S1-P91 |
Ejemplares similares
-
Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance
por: Jones, Sam, et al.
Publicado: (2019) -
Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling
por: Hodel, Eva Maria, et al.
Publicado: (2014) -
A systematic review of published antimalarial clinical trials: parasite clearance of artemisinin-containing regimens in the treatment of uncomplicated malaria
por: Das, Debashish, et al.
Publicado: (2012) -
The power of pooled analysis to inform optimal dosing strategies for Artemisinin Combination Therapies (ACTs)
por: Guerin, Philippe J, et al.
Publicado: (2012) -
Chemical stability of artemisinin derivatives
por: Van Acker, Kristel, et al.
Publicado: (2012)